Biotechnology Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More – ATAI Life Sciences (NASDAQ:ATAI), Algernon Pharmaceuticals (OTC:AGNPF) Read more
Biotechnology Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans’ Trips And More – Awakn Life Sciences (OTC:AWKNF), BetterLife Pharma (OTC:BETRF) Read more
Cannabis Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends – Numinus Wellness (OTC:NUMIF) Read more
Cannabis Psychedelics Reform Update: Missouri’s $10M Budget, Maine’s & Maryland’s Study Groups, Oregon’s Re-Crim And More Read more
Cannabis Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More – Compass Pathways (NASDAQ:CMPS), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta’s Influence – ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline – Compass Pathways (NASDAQ:CMPS), ATAI Life Sciences (NASDAQ:ATAI) Read more
Biotechnology Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression – ATAI Life Sciences (NASDAQ:ATAI) Read more
Biotechnology PharmAla’s Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development – Pharmala Biotech Hldgs (OTC:MDXXF) Read more
Cannabis Congress Discusses Remaining FY2024 Spending Bill With Provisions On Cannabis Sales And Psychedelic Clinical Trials Read more
